Literature DB >> 26390094

Gleason pattern 4: active surveillance no more.

Niranjan J Sathianathen1,2, Declan G Murphy1,3, Roderick C N van den Bergh4, Nathan Lawrentschuk1,5,6.   

Abstract

Mesh：

Year:  2015        PMID： 26390094     DOI： 10.1111/bju.13333

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  3 in total

Review 1.  An update on focal therapy for prostate cancer.

Authors:  Marlon Perera; Nishanth Krishnananthan; Uri Lindner; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2016-09-27       Impact factor: 14.432

2.  Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No.

Authors:  Nishanth Krishnananthan; Nathan Lawrentschuk
Journal:  Int Braz J Urol       Date:  2016 May-Jun       Impact factor: 1.541

Review 3.  The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?

Authors:  Niranjan J Sathianathen; Christopher A Warlick
Journal:  World J Mens Health       Date:  2018-09       Impact factor: 5.400
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.